Lamotrigine Tablet, For Suspension
Product Images NDC 46708-096

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 46708-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg 30's Bottle Pack (Lamotrigine 10mg)

Lamotrigine Tablets for Oral Suspension USP, chewable dispersible tablets, 10 mg strength. The label indicates 30 tablets per container, manufactured by Alembic Pharmaceuticals Limited. Additional information includes storage instructions, phenylketonurics warning, NDC 46708-096-30, and directions to dispense the accompanying medication guide to patients.*

FDA Label Image

5 mg 30's Bottle Pack (Lamotrigine 5mg)

Label for lamotrigine chewable dispersible tablets for oral suspension USP, 5 mg strength. The label states the product contains 30 tablets, is prescription only, and is manufactured by Alembic Pharmaceuticals Limited. It includes storage instructions, a caution to verify product dispensed, and a barcode with NDC 46708-095-30.*

FDA Label Image

Figure 1 (Lamotrigine Figure1)

A Kaplan-Meier failure probability graph comparing lamotrigine versus placebo treatment over approximately 100 weeks. The y-axis represents failure probability in percentage, while the x-axis shows weeks. Two lines indicate failure probabilities for lamotrigine and placebo groups, with censored data marked by plus signs.*

FDA Label Image

Figure 2 (Lamotrigine Figure2)

A line graph depicting failure probability (%) over a period of weeks for lamotrigine chewable dispersible tablet compared to placebo. The x-axis represents weeks up to 80, and the y-axis shows failure probability from 0% to 100%. Two lines represent lamotrigine and placebo, with censored data points marked.*

FDA Label Image

Structure (Lamotrigine Structure)

Chemical structure of lamotrigine showing the molecular arrangement including chlorine atoms, nitrogen atoms, and an amino group as part of its heterocyclic compound framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.